Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03763201
What this trial is testing

Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Benha University 50
Not applicableActive Not RecruitingNCT06513507
What this trial is testing

A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.

Who this might be right for
Rheumatoid ArthritisInflammatory Disease
Raphael Pharma 12
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Testing effectiveness (Phase 2)Study completedNCT00810836
What this trial is testing

Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01597739
What this trial is testing

JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 96
Testing effectiveness (Phase 2)Ended earlyNCT02270632
What this trial is testing

A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX

Who this might be right for
Rheumatoid Arthritis
Philogen S.p.A. 27
Post-approval studies (Phase 4)Study completedNCT00157872
What this trial is testing

Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Who this might be right for
Rheumatoid Arthritis
Merck Sharp & Dohme LLC 150
Testing effectiveness (Phase 2)Study completedNCT00687193
What this trial is testing

Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan

Who this might be right for
Arthritis, Rheumatoid
Pfizer 318
Testing effectiveness (Phase 2)Study completedNCT00626275
What this trial is testing

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 46
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Not applicableUnknownNCT01071863
What this trial is testing

Association of Fear of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological Therapy

Who this might be right for
Rheumatoid Arthritis
Newcastle-upon-Tyne Hospitals NHS Trust 40
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Not applicableWithdrawnNCT03428763
What this trial is testing

ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, RheumatoidTelerehabilitation
Frederiksberg University Hospital
Not applicableStudy completedNCT01656278
What this trial is testing

An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis

Who this might be right for
ArthritisArthritis, RheumatoidJoint Diseases+4 more
Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen 200
Not applicableUnknownNCT03170947
What this trial is testing

Effects of Insoles in Patients With Rheumatoid Arthritis: Randomized Controlled Trial.

Who this might be right for
Rheumatoid Arthritis
University of Malaga 96
Testing effectiveness (Phase 2)Study completedNCT05665985
What this trial is testing

Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Universitas Sebelas Maret 30
Early research (Phase 1)Study completedNCT02277574
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
MedImmune LLC 29
Large-scale testing (Phase 3)Study completedNCT01353859
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 39
Next Page